Dr. Anthony Fauci, the Director of the National Institute of Allergy and Infectious Diseases, spoke out this week to say that babies and toddlers aged six months to five years could be eligible for the COVID-19 shot by early next year.
“Hopefully within a reasonably short period of time, likely the beginning of next year in 2022, in the first quarter of 2022, it will be available to them,” Fauci told Insider, He then made sure to add that “you’ve got to do the clinical trial” before this can happen.
This comes after Pfizer-BioNTech stated that their clinical trial in children in the age ranges of two to five years and six months to two years could be released as early as the fourth quarter of the year.
ABC Tampa reported in late October that Pfizer was expecting to be applying for approval for its COVID-19 shot in children ages six months to five years, which is the last age range in the United States that has yet to be approved to be jabbed, at some point this month.
“The Food and Drug Administration and CDC won’t approve the vaccine until there’s some data showing safety and efficacy,” Philip Landrigan, a pediatrician and immunologist at Boston College, told CNN Health earlier in November.
“There’s every reason to think that it will be safe, and it will be efficacious,” Landrigan added. “But the agencies need to be cautious, justifiably so, and so they’re not going to give the approval until they have the data.”
While Pfizer is said to be the furthest along in trials for those aged six months to five years, Moderna is also currently conducting trials on extremely young children.
“We don’t have enough data now to present it for a regulatory approach, but right now, the data are being collected and analyzed,” Fauci said in another interview earlier this month. “So we will be able to answer the question, I believe, within a reasonable period of time regarding the safety and the immunogenicity among those lower than five years old.”
President Joe Biden’s White House announced earlier this week that 10% of children ages five to 11 have received their first coronavirus shot in the wake of the Pfizer pediatric shot being approved.
Experts like Dr. Ben Carson, however, have spoken out against the FDA approving COVID-19 shots for children, saying that the jabs have had adverse effects on kids.
“We don’t know what the long-term impact of these vaccines is, so this is really sort of a giant experiment. Do we want to put our children at risk, when we know that the risk of the disease to them is relatively small, but we don’t know what the future risks are, why would we do a thing like that?” Carson said earlier this month, according to Newsweek. “It makes no sense whatsoever.”
Red Voice Media would like to make a point of clarification on why we do not refer to any shot related to COVID-19 as a "vaccine." According to the CDC, the definition of a vaccine necessitates that said vaccine have a lasting effect of at least one year in preventing the contraction of the virus or disease it's intended to fight. Because all of the COVID-19 shots thus far available have barely offered six months of protection, and even then not absolute, Red Voice Media has made the decision hereafter to no longer refer to the Pfizer, Moderna, or Johnson & Johnson substances as vaccinations.